Entries by bps

[Chosun Ilbo] Many Patients and their Families “Desperately Need a New Epilepsy Drug. We Must Continue to Conduct Research for them.”

Dr. Choi Yong-moon has been developing this drug for 7 years. Four thousand people suffer from ‘status epilepticus’ in Korea alone. The ‘status epilepticus’ passed FDA phase 1 clinical trial. “Stop the unstoppable epileptic seizure.” Mr. Choi Yong-moon, CEO of Bio-Pharm Solutions, a pharmaceutical venture, is focused on ‘status epilepticus.’ As the epileptic seizure […]

IR/PR

The oral medication for infantile spasms (IS) is in phase 2 clinical trialsin Korea and the US, and the IV medication for status epilepticus (SE) is in phase 1 clinical trials in the US. The company has established new pipelines, including Alzheimer’s Disease, and is set to embark on clinical trials (phase 2)… by expanding […]

IR/PR

The oral medication for infantile spasms (IS) is in phase 2 clinical trialsin Korea and the US, and the IV medication for status epilepticus (SE) is in phase 1 clinical trials in the US. The company has established new pipelines, including Alzheimer’s Disease, and is set to embark on clinical trials (phase 2)… by expanding […]

Bio-Pharm Solutions

145, Gwanggyo-ro, Yeongtong-gu, Suwon,
Gyeonggi-do, 16229, Korea
6F, C Bldg, Advanced Institute of Convergence Technology

CONTACT

Tel: 82-31-888-9608
Fax: 82-31-888-9601

MORE

Careers: shkim@b-psol.com
Clinical Trials: hsshin@b-psol.com
Investor Inquiries: uklee@b-psol.com
BD Partnering: uklee@b-psol.com